Clinical Trial: A Novel Intraoperative Fluorescence-guided System for Evaluating Margins During Breast-conserving Surgery for Breast Cancer: A Prospective Non-randomized Controlled Trial

U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07352930) titled 'A Novel Intraoperative Fluorescence-guided System for Evaluating Margins During Breast-conserving Surgery for Breast Cancer: A Prospective Non-randomized Controlled Trial' on Jan. 13.

Brief Summary: The goal of this clinical trial is to learn if a novel intraoperative fluorescence-guided system (EndoSCell Scanner) can help surgeons more accurately remove all cancerous tissue during breast-conserving surgery in female patients aged 18 years or older, with primary breast cancer. The main questions it aims to answer are:

* Does the use of the EndoSCell Scanner system lower the rate of secondary surgeries needed due to positive cancer ...